Bio-Techne Corp (TECH)

Operating profit margin

		Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Operating income	US$ in thousands	242,804	206,686	298,944	296,590	149,549
Revenue	US$ in thousands	1,219,640	1,159,060	1,136,700	1,105,600	931,032
Operating profit margin		19.91%	17.83%	26.30%	26.83%	16.06%

June 30, 2025 calculation

Operating profit margin = Operating income ÷ Revenue
= $242,804K ÷ $1,219,640K
= 19.91%

The operating profit margin of Bio-Techne Corp has exhibited notable variations over the specified period from June 30, 2021, to June 30, 2025. In the fiscal year ending June 30, 2021, the company reported an operating profit margin of 16.06%, representing a relatively modest level of operational efficiency and profitability relative to revenue.

By June 30, 2022, the operating profit margin significantly increased to 26.83%, indicating a substantial improvement in operational performance, potentially driven by higher revenue, improved cost management, or a combination of both. This surge suggests that the company was able to convert a larger portion of its sales into operating profit during this period.

However, in the subsequent year ending June 30, 2023, the operating profit margin slightly declined to 26.30%. Despite this decrease, the margin remained substantially high compared to the 2021 figure, continuing to reflect strong operational efficiency. The slight reduction could be attributed to increased costs, competitive pressures, or strategic adjustments affecting margins.

In the fiscal year ending June 30, 2024, the operating profit margin further declined to 17.83%. This notable decrease might signal increased operating expenses, reduced pricing power, or other operational challenges impacting profitability margins. Despite the decline, the margin remained above the 2021 level, indicating some resilience.

Looking ahead to June 30, 2025, the operating profit margin improves modestly to 19.91%. This recovery suggests a stabilization or a potential improvement in operational efficiencies, cost controls, or revenue growth strategies. The upward trend in this year reflects an optimistic outlook towards restoring or enhancing profitability margins.

Overall, the operating profit margin of Bio-Techne Corp experienced initial growth followed by periods of decline and partial recovery. The historical pattern indicates fluctuating operational profitability, with the most recent figures suggesting a cautiously optimistic outlook for margin improvement.